Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome

Pharmacogenomics

Volumn 11, Issue 12, 2010, Pages 1733-1741

  Liao, Isaac H ^a   Corbett, Blythe A ^a   Gilbert, Donald L ^b   Bunge, Silvia A ^c   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GABRE; gene expression; microarray; NPAS4; phenylethanolamine N methyltransferase; PNMT; Tourette Syndrome

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR EPSILON; CATECHOLAMINE; DOPAMINE 2 RECEPTOR; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CATECHOLAMINE METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION REGULATION; GENOME ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MICROARRAY ANALYSIS; NEUROMODULATION; NORADRENERGIC SYSTEM; QUANTITATIVE ANALYSIS; RNA ISOLATION; SCHOOL CHILD; TIC;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEVERITY OF ILLNESS INDEX; TICS; TOURETTE SYNDROME;

EID: 78650393944     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.160     Document Type: Article

References (30)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: (Revised 4th Edition). Washington, DC, USA, 111-114 (2000).
2. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF: Tourette syndrome and tic disorders: a decade of progress. J. Am. Acad. Child Adolesc. Psychiatry 46, 947-968 (2007).
3. Müller N: Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches. Dialogues Clin. Neurosci. 9, 161-171 (2007).
4. Singer HS: Tourette's syndrome: from behaviour to biology. Lancet Neurol. 4, 149-159 (2005).
5. Lit L, Gilbert DL, Walker W, Sharp FRA: Subgroup of Tourette's patients overexpress specifc natural killer cell genes in blood: a preliminary report. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144B, 958-963 (2007).
6. Baym CL, Corbett BA, Wright SB, Bunge SA: Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain 131, 165-179 (2008).
7. Leckman JF, Riddle MA, Hardin MT et al.: The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry 28, 566-573 (1989).
8. Srour M, Lespérance P, Richer F, Chouinard S: Psychopharmacology of tic disorders. J. Can. Acad. Child Adolesc. Psychiatry 17, 150-159 (2008).
9. Ogata H, Susumu G, Kazushige S et al.: KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic. Acids Res. 27, 29-34 (1999).
10. Blake JA, Harris MA: The Gene Ontology project: structured vocabularies for molecular biology and their application to genome and expression analysis. Curr. Protoc. Bioinformatics Chapter 7, Unit 7.2 (2002).
11. Sands S, Dickerson D, Morris S, Chronwall B: Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes. Endocrine 6, 325-333 (1997). (Pubitemid 27431405)
12. Dunn SM, Bateson AN, Martin IL: Molecular neurobiology of the GABAA receptor. Int. Rev. Neurobiol. 36, 51-96 (1994).
13. A receptor. J. Neurosci. 25, 10462-10468 (2005).
14. Ranna M, Sinkkonen ST, Möykkynen T, Uusi-Oukari M, Korpi ER: Impact of e and q subunits on pharmacological properties of a3b1 GABAA receptors expressed in Xenopus oocytes. BMC Pharmacol. 6, 1 (2006).
15. Carlton SM, Honda CN, Denoroy L: Distribution of phenylethanolamine N-methyltransferase cell bodies, axons, and terminals in monkey brainstem: an immunohistochemical mapping study. J. Comp. Neurol. 287, 273-285 (1989).
16. Milner TA, Abate C, Reis DJ, Pickel VM: Ultrastructural localization of phenylethanolamine N-methyltransferase-like immunoreactivity in the rat locus coeruleus. Brain Res. 478, 1-15 (1989).
17. Mejías-Aponte CA, Drouin C, Aston-Jones G: Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J. Neurosci. 29, 3613-3626 (2009).
18. Moragues N, Ciof P, Tramu G, Garret M: Localisation of GABA(A) receptor e-subunit in cholinergic and aminergic neurones and evidence for codistribution with the q-subunit in rat brain. Neuroscience 111, 657-669 (2002).
19. A receptor e and q subunits display unusual structural variation between species and are enriched in the rat locus ceruleus. J. Neurosci. 20, 3588-3595 (2000).
20. Nagatsu I, Ikemoto K, Takeuchi T et al.: Phenylethanolamine-N- methyltransferase - immunoreactive nerve terminals afferent to the mouse substantia nigra. Neuroscience Letters 245, 41-44 (1998).
21. Keck PE, McElroy SL, Strakowski SM, Soutullo CA: Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. J. Clin. Psychiatry 61(Suppl. 4), 33-38 (2000).
22. Elias AN, Hoffich H: Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications. Am. J. Med. 121, 98-104 (2008).
23. Lin Y, Bloodgood BL, Hauser JL et al.: Activity-dependent regulation of inhibitory synapse development by NPAS4. Nature 455, 1198-1204 (2008).
24. Kalanithi PSA Zheng W, Kataoka Y et al.: Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. USA 102, 13307-13312 (2005).
25. Dan B, Boyd SG: Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis. Neuropediatrics 34, 169-176 (2003).
26. Comings DE: Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann. N. Y. Acad. Sci 931, 50-83 (2001).
27. Wu S, Wang WF, Shyu HY et al.: Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study. Neurosci. Lett. 478, 61-65 (2010).
28. Cordelier P, Estève J P, Najib S et al.: Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation. J. Biol. Chem. 281, 19156-19171 (2006).
29. Kulisevsky J, Litvan I, Berthier ML et al.: Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov. Disord. 16, 1098-1104 (2001).
30. Mieczkowski J, Tyburczy M, Dabrowski M, Pokarowski P: Probe set fltering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements. BMC Bioinformatics 11, 104 (2010).